Villumsen M, Poulsen G, Andersen NN, Andersson M, et al. Anti-Tumor Necrosis Factor Treatment does not decrease the Risk of Type 2 Diabetes in Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2022 Dec 22:S1542-3565(22)01178.
PMID: 36566818